全文获取类型
收费全文 | 2830篇 |
免费 | 154篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 78篇 |
妇产科学 | 64篇 |
基础医学 | 442篇 |
口腔科学 | 31篇 |
临床医学 | 219篇 |
内科学 | 678篇 |
皮肤病学 | 53篇 |
神经病学 | 382篇 |
特种医学 | 61篇 |
外科学 | 222篇 |
综合类 | 3篇 |
一般理论 | 1篇 |
预防医学 | 140篇 |
眼科学 | 21篇 |
药学 | 218篇 |
中国医学 | 28篇 |
肿瘤学 | 351篇 |
出版年
2024年 | 5篇 |
2023年 | 26篇 |
2022年 | 55篇 |
2021年 | 84篇 |
2020年 | 55篇 |
2019年 | 46篇 |
2018年 | 78篇 |
2017年 | 65篇 |
2016年 | 55篇 |
2015年 | 89篇 |
2014年 | 91篇 |
2013年 | 140篇 |
2012年 | 220篇 |
2011年 | 212篇 |
2010年 | 112篇 |
2009年 | 110篇 |
2008年 | 208篇 |
2007年 | 237篇 |
2006年 | 205篇 |
2005年 | 169篇 |
2004年 | 181篇 |
2003年 | 139篇 |
2002年 | 112篇 |
2001年 | 23篇 |
2000年 | 20篇 |
1999年 | 19篇 |
1998年 | 27篇 |
1997年 | 16篇 |
1996年 | 23篇 |
1995年 | 18篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 13篇 |
1991年 | 24篇 |
1990年 | 19篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 7篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1975年 | 4篇 |
1974年 | 2篇 |
1973年 | 4篇 |
1971年 | 3篇 |
1970年 | 2篇 |
1969年 | 2篇 |
排序方式: 共有2999条查询结果,搜索用时 46 毫秒
51.
A relaxometric method for the assessment of intestinal permeability based on the oral administration of gadolinium‐based MRI contrast agents
下载免费PDF全文
![点击此处可从《NMR in biomedicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Eliana Gianolio Cinzia Boffa Valeria Orecchia Paola Bardini Valeria Catanzaro Valeria Poli Silvio Aime 《NMR in biomedicine》2016,29(4):475-482
Herein, a new relaxometric method for the assessment of intestinal permeability based on the oral administration of clinically approved gadolinium (Gd)‐based MRI contrast agents (CAs) is proposed. The fast, easily performed and cheap measurement of the longitudinal water proton relaxation rate (R1) in urine reports the amount of paramagnetic probe that has escaped the gastrointestinal tract. The proposed method appears to be a compelling alternative to the available methods for the assessment of intestinal permeability. The method was tested on the murine model of dextran sulfate sodium (DSS)‐induced colitis in comparison with healthy mice. Three CAs were tested, namely ProHance®, MultiHance® and Magnevist®. Urine was collected for 24 h after the oral ingestion of the Gd‐containing CA at day 3–4 (severe damage stage) and day 8–9 (recovery stage) after treatment with DSS. The Gd content in urine measured by 1H relaxometry was confirmed by inductively coupled plasma‐mass spectrometry (ICP‐MS). The extent of urinary excretion was given as a percentage of excreted Gd over the total ingested dose. The method was validated by comparing the results obtained with the established methodology based on the lactulose/mannitol and sucralose tests. For ProHance and Magnevist, the excreted amounts in the severe stage of damage were 2.5–3 times higher than in control mice. At the recovery stage, no significant differences were observed with respect to healthy mice. Overall, a very good correlation with the lactulose/mannitol and sucralose results was obtained. In the case of MultiHance, the percentage of excreted Gd complex was not significantly different from that of control mice in either the severe or recovery stages. The difference from ProHance and Magnevist was explained on the basis of the (known) partial biliary excretion of MultiHance in mice. Copyright © 2016 John Wiley & Sons, Ltd. 相似文献
52.
A. Sara De Tommasi Gad Baneth Edward B. Breitschwerdt Dorothee Stanneck Filipe Dantas-Torres Domenico Otranto Donato de Caprariis 《Journal of clinical microbiology》2014,52(6):2231-2234
Anaplasma platys is an obligate intracellular rickettsial pathogen that infects platelets of dogs, forming basophilic intracellular morulae. In the present report, cellular inclusions were documented in bone marrow thrombocyte precursors of two young naturally infected dogs, indicating that A. platys can infect megakaryocytes and promegakaryocytes. 相似文献
53.
54.
55.
56.
57.
Bertini M Ziacchi M Biffi M Martignani C Saporito D Valzania C Diemberger I Cervi E Frisoni J Sangiorgi D Branzi A Boriani G 《The American journal of cardiology》2008,102(10):1373-1377
Present devices for cardiac resynchronization therapy offer the possibility of tailoring the hemodynamic effect of biventricular pacing by optimization of the interventricular delay (VV) beyond atrioventricular (AV)-interval optimization. It was not yet defined whether a QRS width-based strategy may be a helpful tool for echocardiography for device programming. The aim of the study was to investigate the relation between VV-interval optimization guided by echocardiography and guided by QRS interval width. One hundred six patients with a cardiac resynchronization therapy device for > or =3 months were enrolled. All patients underwent echocardiographic AV and VV delay optimization. The AV interval was optimized according to the E wave-A wave (EA) interval and left ventricular filling time. At the optimal AV delay, VV optimization was performed by measuring the aortic velocity time integral at 5 different settings: simultaneous right and left ventricle output, left ventricle pre-excitation (left ventricle + 40 and 80 ms, respectively), and right ventricle pre-excitation (right ventricle + 40 and 80 ms, respectively). A 12-lead electrocardiogram was recorded and QRS duration was measured in the lead with the greatest QRS width. The electrocardiographic (ECG)-optimized VV interval was defined according to the narrowest achievable QRS interval among 5 VV intervals. The echocardiographic-optimized VV interval was left ventricle + 40 ms in 28 patients, left ventricle + 80 ms in 15 patients, simultaneous in 46 patients, right ventricle + 40 ms in 14 patients, and right ventricle + 80 ms in 3 patients. Significant concordance (kappa = 0.69, p <0.001) was found between the echocardiographic- and ECG-optimized VV interval. In conclusion, significant concordance appeared to exist during biventricular pacing between VV programming based on the shortest QRS interval at 12-lead ECG pacing and echocardiographic-guided VV-interval optimization. A combined ECG- and echocardiographic approach could be a less time-consuming solution in performing this operation. 相似文献
58.
59.
Transcriptional regulation of human sodium/iodide symporter gene: a role for redox factor-1 总被引:11,自引:0,他引:11
Puppin C Arturi F Ferretti E Russo D Sacco R Tell G Damante G Filetti S 《Endocrinology》2004,145(3):1290-1293
60.
Paolo Ortolani Antonio Marzocchi Cinzia Marrozzini Tullio Palmerini Francesco Saia Carlo Serantoni Matteo Aquilina Simona Silenzi Federica Baldazzi Daniele Grosseto Nevio Taglieri Robin M T Cooke Maria Letizia Bacchi-Reggiani Angelo Branzi 《European heart journal》2006,27(13):1550-1557
AIMS: Treatment delay is a powerful predictor of survival in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). We investigated effectiveness of pre-hospital diagnosis of STEMI with direct referral to PCI, alongside more conventional referral strategies. METHODS AND RESULTS: From January 2003 to December 2004, 658 STEMI patients were referred for primary PCI at our intervention laboratory. Three predefined referral routes were compared: (1) for patients within 90 min drive of the PCI centre, pre-hospital diagnosis and direct transportation (n=166), (2) diagnosis at the interventional hospital emergency department (n=316), (3) diagnosis at local hospitals before transportation (n = 176). Pre-hospital diagnosis was associated with more than 45 min reduction in treatment delay (P = 0.001). No significant difference in in-hospital mortality was apparent in the overall study population. In the cardiogenic shock subgroup (n = 80), pre-hospital diagnosis was associated with a two-thirds reduction in in-hospital mortality (P = 0.019); mortality was only 6.2% in shock patients who underwent PCI in < 2 h. CONCLUSION: This study shows that pre-hospital diagnosis can provide a reduction in primary PCI treatment delay, and suggests the hypothesis that this referral strategy might provide survival benefits to patients with cardiogenic shock. 相似文献